On Jun. 13, 2020, AstraZeneca announced an agreement with Europeﾒs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxfordﾒs COVID-19 vaccine, with deliveries starting by the end of 2020.

p>The Company completed similar agreements with the UK, U.S., the Coalition for Epidemic Preparedness Innovations and Gavi the Vaccine Alliance for 700 million doses, and it agreed a licence with the Serum Institute of India for the supply of an additional one billion doses, principally for low- and middle-income countries. Total manufacturing capacity currently stands at two billion doses.

.